Skip to main content

Genetics disease risk

Genetic, environmental factors in disease risk, new insights found




Environmental factors may play a larger role in disease risk than previously thought, overshadowing genetic contributions, a study by researchers at Penn State College of Medicine reveals.

Published in the journal Nature Communications, the research shows that lifestyle and environmental factors, such as air pollution, can significantly influence disease risk, offering more opportunities for mitigation.

“We’re trying to disentangle how much genetics and environment influences the development of disease,” said Bibo Jiang, assistant professor of public health sciences.

The team used a novel spatial mixed linear effect model, combining genetics and geolocation data, to analyse disease risks.

Co-senior author Dajiang Liu emphasised the importance of separating environmental influences from genetic factors, “If we can tease apart these shared environments, what’s remaining could more accurately reflect genetic heritability of disease.”

Using data from IBM MarketScan and environmental data, the researchers re-evaluated the genetic contributions to various diseases.

For example, the genetic risk of type 2 diabetes was recalibrated from 37.7 per cent to 28.4 per cent, highlighting a greater role for environmental factors. Similarly, the genetic contribution to obesity risk decreased from 53.1 per cent to 46.3 per cent.

The study also distinguished the effects of specific pollutants, such as PM2.5 and NO2, on health conditions. NO2 was found to directly influence conditions like high cholesterol and diabetes, whereas PM2.5 impacted lung function and sleep disorders.

This research suggests that understanding the balance between genetic and environmental factors can enhance disease prevention strategies, particularly in precision medicine.

Genetic disorders, hereditary diseases, DNA mutations, gene therapy, genetic testing, chromosomal abnormalities, inherited conditions, genetic predisposition, genomics, personalized medicine, rare diseases, familial risk, genetic counseling, autosomal recessive, autosomal dominant, carrier screening, molecular genetics, gene editing, epigenetics, genetic markers.

#GeneticDisorders #HereditaryDiseases #DNAMutations #GeneTherapy #GeneticTesting #ChromosomalAbnormalities #InheritedConditions #GeneticPredisposition #Genomics #PersonalizedMedicine #RareDiseases #FamilialRisk #GeneticCounseling #AutosomalRecessive #AutosomalDominant #CarrierScreening #MolecularGenetics #GeneEditing #Epigenetics #GeneticMarkers

International Conference on Genetics and Genomics of Diseases

Visit: genetics-conferences.healthcarek.com

Award Nomination: x-i.me/gennom1
Award registration: x-i.me/genreg2
Member Nomination: x-i.me/genmember
Member Registration: x-i.me/genreg1
For Enquiries: genetics@healthcarek.com


Get Connected Here
---------------------------------
---------------------------------

Pinterest: x-i.me/genpt
Twitter: x-i.me/gentw
Facebook: x-i.me/genfb
Instagram: x-i.me/genin
Youtube: x-i.me/genyt

Comments

Popular posts from this blog

Fruitful innovation

Fruitful innovation: Transforming watermelon genetics with advanced base editors The development of new adenine base editors (ABE) and adenine-to-thymine/ guanine base editors (AKBE) is transforming watermelon genetic engineering. These innovative tools enable precise A:T-to-G and A:T-to-T base substitutions, allowing for targeted genetic modifications. The research highlights the efficiency of these editors in generating specific mutations, such as a flowerless phenotype in ClFT (Y84H) mutant plants. This advancement not only enhances the understanding of gene function but also significantly improves molecular breeding, paving the way for more efficient watermelon crop improvement. Traditional breeding methods for watermelon often face challenges in achieving desired genetic traits efficiently and accurately. While CRISPR/Cas9 has provided a powerful tool for genome editing, its precision and scope are sometimes limited. These limitations highlight the need for more advanced gene-e...

Genetic factors with clinical trial stoppage

Genetic factors associated with reasons for clinical trial stoppage Many drug discovery projects are started but few progress fully through clinical trials to approval. Previous work has shown that human genetics support for the therapeutic hypothesis increases the chance of trial progression. Here, we applied natural language processing to classify the free-text reasons for 28,561 clinical trials that stopped before their endpoints were met. We then evaluated these classes in light of the underlying evidence for the therapeutic hypothesis and target properties. We found that trials are more likely to stop because of a lack of efficacy in the absence of strong genetic evidence from human populations or genetically modified animal models. Furthermore, certain trials are more likely to stop for safety reasons if the drug target gene is highly constrained in human populations and if the gene is broadly expressed across tissues. These results support the growing use of human genetics to ...

Genetics study on COVID-19

Large genetic study on severe COVID-19 Bonn researchers confirm three other genes for increased risk in addition to the known TLR7 gene Whether or not a person becomes seriously ill with COVID-19 depends, among other things, on genetic factors. With this in mind, researchers from the University Hospital Bonn (UKB) and the University of Bonn, in cooperation with other research teams from Germany, the Netherlands, Spain and Italy, investigated a particularly large group of affected individuals. They confirmed the central and already known role of the TLR7 gene in severe courses of the disease in men, but were also able to find evidence for a contribution of the gene in women. In addition, they were able to show that genetic changes in three other genes of the innate immune system contribute to severe COVID-19. The results have now been published in the journal " Human Genetics and Genomics Advances ". Even though the number of severe cases following infection with the SARS-CoV-...